Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats-Reference-Cited by-同舟云学术

Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats

Published:2023-03-31 Issue:10 Volume:13 Page:2568-2588
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Elmowafy Mohammed^ORCID,Shalaby Khaled,Elkomy Mohammed H.,Alsaidan Omar Awad,Gomaa Hesham A. M.,Hendawy Omnia M.,Abdelgawad Mohamed A.,Ali Hazim M.,Ahmed Yasmin M.,El-Say Khalid M.

Funder

Deanship of Scientific Research at Jouf University

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-023-01338-3.pdf

Reference89 articles.

1. Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release. Eur J Pharm Biopharm. 2005;59(2):367–71.

2. Krishnaiah YSR, Satyanarayana V, Kumar BD, Karthikeyan RS. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 2002;16(3):185–92.

3. Ying K, Bai B, Gao X, Xu Y, Wang H. Orally administrable therapeutic nanoparticles for the treatment of colorectal cancer. 2021;9(July):1–20.